ENDRA Life Sciences Inc.
NDRA- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001681682
No open-market purchases or sales by ENDRA Life Sciences Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $819.0K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding ENDRA Life Sciences Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 23 | 20 | −3 |
| Shares | 3.56M | 3.50M | −53.6K (−1.5%) |
| Value | $7.75M | $6.06M | −$1.69M (−21.8%) |
New holders (2)
Institutions that held ENDRA Life Sciences Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 15,264 | $26.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 50 | $0 | 0.00% |
Sold out (5)
Institutions that held ENDRA Life Sciences Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Goldman Sachs Group Inc | 47,709 | $104.0K |
| National Asset Management, Inc. | 29,700 | $65.0K |
| Tranquility Partners, LLC | 12,750 | $28.0K |
| Stifel Financial Corp | 12,500 | $27.0K |
| Bank of America Corp | 16 | $0 |